advertisement

HaagStreit

11.16 Vehicles, delivery systems, pharmacokinetics, formulation (107)

Showing records 1 to 25

Display all abstracts in classification 11.16 Vehicles, delivery systems, pharmacokinetics, formulation

Search within classification 11.16 Vehicles, delivery systems, pharmacokinetics, formulation
80090 Rho kinase inhibitors for treatment of glaucoma
Mandell KJ
Expert Review of Ophthalmology 2011; 6: 611-622
79933 Simultaneous co-delivery of neuroprotective drugs from multi-loaded PLGA microspheres for the treatment of glaucoma
Arranz-Romera A
Journal of Controlled Release 2019; 297: 26-38
79378 Brinzolamide-loaded nanoemulsions: ex vivo transcorneal permeation, cell viability and ocular irritation tests
Mahboobian MM
Pharmaceutical Development and Technology 2019; 24: 600-606
79769 Thermo-sensitive nanogel-laden bicontinuous microemulsion drug-eluting contact lenses
Lee SH
Journal of Biomedical Materials Research - Part B Applied Biomaterials 2019; 107: 1159-1169
80027 Effect of gold nanoparticles on timolol uptake and its release kinetics from contact lenses: In vitro and in vivo evaluation
Maulvi FA
Acta biomaterialia 2019; 86: 350-362
79383 Thermosensitive chitosan-gelatin-based hydrogel containing curcumin-loaded nanoparticles and latanoprost as a dual-drug delivery system for glaucoma treatment
Cheng YH
Experimental Eye Research 2019; 179: 179-187
80054 Co-Delivery of Timolol and Brimonidine with a Polymer Thin-Film Intraocular Device
Samy KE
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 124-131
79521 Local Delivery and Sustained-Release of Nitric Oxide Donor Loaded in Mesoporous Silica Particles for Efficient Treatment of Primary Open-Angle Glaucoma
Hu C
Advanced healthcare materials 2018; 7: e1801047
79363 Efficacy and safety of preservative-free timolol 0.1% gel in open-angle glaucoma and ocular hypertension in treatment-naïve patients and patients intolerant to other hypotensive medications
Lazreg S
Journal Franšais d'Ophtalmologie 2018; 41: 945-954
79765 Better tolerance of preservative-free latanoprost compared to preserved glaucoma eye drops: the 12-month real-life FREE study
Economou MA
Clinical Ophthalmology 2018; 12: 2399-2407
79825 Engineering and Development of Chitosan-Based Nanocoatings for Ocular Contact Lenses
Mehta P
Journal of Pharmaceutical Sciences 2019; 108: 1540-1551
79583 Conjunctival Goblet Cells, the Overlooked Cells in Glaucoma Treatment
Tiedemann D
Journal of Glaucoma 2019; 28: 325-333
79689 Latanoprost with high precision, piezo-print microdose delivery for IOP lowering: clinical results of the PG21 study of 0.4 µg daily microdose
Pasquale LR
Clinical Ophthalmology 2018; 12: 2451-2457
80061 Effect of vitamin-E integration on delivery of prostaglandin analogs from therapeutic lenses
Sekar P
Journal of Colloid and Interface Science 2019; 539: 457-467
79726 Gelatinized core liposomes: A new Trojan horse for the development of a novel timolol maleate glaucoma medication
Hathout RM
International Journal of Pharmaceutics 2019; 556: 192-199
79766 Efficacy of the travoprost/timolol fixed combination versus the concomitant use of travoprost 0.004% and timolol 0.1% gel formulation
Kozobolis V
Clinical Ophthalmology 2018; 12: 2393-2398
79378 Brinzolamide-loaded nanoemulsions: ex vivo transcorneal permeation, cell viability and ocular irritation tests
Seyfoddin A
Pharmaceutical Development and Technology 2019; 24: 600-606
80061 Effect of vitamin-E integration on delivery of prostaglandin analogs from therapeutic lenses
Chauhan A
Journal of Colloid and Interface Science 2019; 539: 457-467
79521 Local Delivery and Sustained-Release of Nitric Oxide Donor Loaded in Mesoporous Silica Particles for Efficient Treatment of Primary Open-Angle Glaucoma
Sun J
Advanced healthcare materials 2018; 7: e1801047
79363 Efficacy and safety of preservative-free timolol 0.1% gel in open-angle glaucoma and ocular hypertension in treatment-naïve patients and patients intolerant to other hypotensive medications
Merad Z
Journal Franšais d'Ophtalmologie 2018; 41: 945-954
79765 Better tolerance of preservative-free latanoprost compared to preserved glaucoma eye drops: the 12-month real-life FREE study
Laukeland HK
Clinical Ophthalmology 2018; 12: 2399-2407
79933 Simultaneous co-delivery of neuroprotective drugs from multi-loaded PLGA microspheres for the treatment of glaucoma
Davis BM
Journal of Controlled Release 2019; 297: 26-38
80090 Rho kinase inhibitors for treatment of glaucoma
Kudelka MR
Expert Review of Ophthalmology 2011; 6: 611-622
80054 Co-Delivery of Timolol and Brimonidine with a Polymer Thin-Film Intraocular Device
Cao Y
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 124-131
79766 Efficacy of the travoprost/timolol fixed combination versus the concomitant use of travoprost 0.004% and timolol 0.1% gel formulation
Konstantinidis A
Clinical Ophthalmology 2018; 12: 2393-2398

Issue 20-2

Select Issue


advertisement

HaagStreit